AIGH Capital Management
Latest statistics and disclosures from AIGH Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ASPN, SCPH, INDI, TGAN, OUST, and represent 38.52% of AIGH Capital Management's stock portfolio.
- Added to shares of these 10 stocks: LPSN (+$6.1M), SCPH (+$5.6M), PROF (+$5.5M), INAB (+$5.2M), DCTH, THTX, RCAT, OUST, COYA, CLRB.
- Started 7 new stock positions in PROF, RCAT, LPSN, TFFP, INAB, DCTH, VERU.
- Reduced shares in these 10 stocks: ANIP (-$16M), AVNW (-$9.9M), MRAM (-$8.3M), , CLNN, GSIT, AIRG, ASRT, KPTI, CVV.
- Sold out of its positions in ANIP, AIRG, ANVS, ASRT, AVNW, BWEN, CVV, CalAmp, B. Riley Wealth Management, Inc. capstone turbine corp, CLNN. MRAM, KPTI, OSA, MDNAF, Tff Pharmaceuticals, TPST.
- AIGH Capital Management was a net seller of stock by $-1.3M.
- AIGH Capital Management has $253M in assets under management (AUM), dropping by 19.39%.
- Central Index Key (CIK): 0001835943
Tip: Access up to 7 years of quarterly data
Positions held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for AIGH Capital Management
AIGH Capital Management holds 39 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Aspen Aerogels (ASPN) | 11.3 | $29M | +2% | 1.8M | 15.78 |
|
| Scpharmaceuticals (SCPH) | 7.7 | $20M | +40% | 3.1M | 6.27 |
|
| Indie Semiconductor Class A Com (INDI) | 7.2 | $18M | +7% | 2.3M | 8.11 |
|
| Transphorm (TGAN) | 6.7 | $17M | 4.6M | 3.65 |
|
|
| Ouster Com New (OUST) | 5.6 | $14M | +44% | 1.9M | 7.67 |
|
| Myomo Com New (MYO) | 5.3 | $13M | +21% | 2.7M | 5.01 |
|
| Electrovaya Com New (ELVA) | 4.1 | $10M | 3.4M | 3.06 |
|
|
| Alimera Sciences Com New (ALIM) | 3.8 | $9.6M | -6% | 2.2M | 4.32 |
|
| Tela Bio (TELA) | 3.6 | $9.1M | +9% | 1.4M | 6.62 |
|
| Biodesix (BDSX) | 3.4 | $8.6M | -5% | 4.7M | 1.84 |
|
| Coya Therapeutics Common Stock (COYA) | 2.9 | $7.4M | +92% | 1.0M | 7.15 |
|
| Brainsway Sponsored Ads (BWAY) | 2.7 | $6.7M | -23% | 1.0M | 6.48 |
|
| Spruce Biosciences (SPRB) | 2.5 | $6.2M | +75% | 2.1M | 2.93 |
|
| LivePerson (LPSN) | 2.4 | $6.1M | NEW | 1.6M | 3.79 |
|
| Theratechnologies Com New (THTX) | 2.4 | $6.0M | +362% | 3.7M | 1.62 |
|
| Applied Therapeutics (APLT) | 2.2 | $5.6M | +109% | 1.7M | 3.35 |
|
| Profound Med Corp Com New (PROF) | 2.2 | $5.5M | NEW | 647k | 8.49 |
|
| Apyx Medical Corporation (APYX) | 2.1 | $5.3M | +7% | 2.0M | 2.62 |
|
| Cellectar Biosciences Com New (CLRB) | 2.1 | $5.3M | +182% | 1.9M | 2.77 |
|
| In8bio (INAB) | 2.1 | $5.2M | NEW | 4.1M | 1.27 |
|
| Delcath Sys Com New (DCTH) | 1.9 | $4.9M | NEW | 1.2M | 4.16 |
|
| Lightpath Technologies Com Cl A (LPTH) | 1.9 | $4.7M | 3.7M | 1.26 |
|
|
| Red Cat Hldgs (RCAT) | 1.7 | $4.4M | NEW | 5.0M | 0.88 |
|
| Bk Technologies Corporation Com New (BKTI) | 1.6 | $4.0M | 331k | 12.23 |
|
|
| Abeona Therapeutics Com New (ABEO) | 1.6 | $3.9M | -30% | 788k | 5.01 |
|
| Cognition Therapeutics (CGTX) | 1.5 | $3.8M | 2.0M | 1.85 |
|
|
| Fennec Pharmaceuticals (FENC) | 1.5 | $3.7M | -11% | 329k | 11.22 |
|
| Elutia Cl A Com (ELUT) | 1.5 | $3.7M | -3% | 1.7M | 2.16 |
|
| GSI Technology (GSIT) | 1.0 | $2.5M | -52% | 945k | 2.64 |
|
| Female Health (VERU) | 1.0 | $2.5M | NEW | 3.4M | 0.72 |
|
| Adverum Biotechnologies | 0.9 | $2.4M | +139% | 3.2M | 0.75 |
|
| Aprea Therapeutics Com New (APRE) | 0.6 | $1.6M | 349k | 4.70 |
|
|
| Franklin Wireless Corporation (FKWL) | 0.5 | $1.3M | 390k | 3.39 |
|
|
| Vaccinex Com New | 0.2 | $543k | -25% | 817k | 0.66 |
|
| Kwesst Micro Systems Com New (KWE) | 0.2 | $501k | 556k | 0.90 |
|
|
| Ideal Pwr Com New (IPWR) | 0.1 | $220k | -69% | 28k | 7.77 |
|
| Tff Pharmaceuticals Com New (TFFP) | 0.1 | $207k | NEW | 30k | 7.02 |
|
| Saverone 2014 *w Exp 06/02/202 (SVREW) | 0.0 | $68k | 568k | 0.12 |
|
|
| Kwesst Micro Systems *w Exp 12/09/202 (KWESW) | 0.0 | $60k | 599k | 0.10 |
|
Past Filings by AIGH Capital Management
SEC 13F filings are viewable for AIGH Capital Management going back to 2020
- AIGH Capital Management 2023 Q4 filed Feb. 12, 2024
- AIGH Capital Management 2023 Q3 filed Nov. 13, 2023
- AIGH Capital Management 2023 Q2 filed Aug. 14, 2023
- AIGH Capital Management 2023 Q1 filed May 15, 2023
- AIGH Capital Management 2022 Q4 filed Feb. 15, 2023
- AIGH Capital Management 2022 Q3 filed Nov. 14, 2022
- AIGH Capital Management 2022 Q2 filed Aug. 12, 2022
- AIGH Capital Management 2022 Q1 filed May 12, 2022
- AIGH Capital Management 2021 Q4 filed Feb. 10, 2022
- AIGH Capital Management 2021 Q3 filed Nov. 12, 2021
- AIGH Capital Management 2021 Q2 filed Aug. 12, 2021
- AIGH Capital Management 2021 Q1 filed May 13, 2021
- AIGH Capital Management 2020 Q4 filed Feb. 16, 2021